Are Country Reputations for Good or Bad AIDS Leadership Deserved? An Exploratory Quantitative Analysis Nicoli Nattrass AIDS & Society Research Unit Centre.

Slides:



Advertisements
Similar presentations
International Security Security UNAIDS INITIATIVE ON HIV/AIDS AND SECURITY NationalSecurityNationalSecurityHumanitarianResponseHumanitarianResponse In.
Advertisements

"3 by 5" progress December 2005 Progress on global access to HIV antiretroviral therapy | 12 April |2 | Antiretroviral therapy coverage in low-
Long-term Projections of the Cost of Treatment Under Various Scenarios – Opportunities for Efficiency and Effectiveness? Arin Dutta, Cathy Barker, and.
People receiving antiretroviral therapy, 2005 to June 2014, all countries.
00003-E-1 – December 2004 Global summary of the HIV and AIDS epidemic, December 2004 The ranges around the estimates in this table define the boundaries.
The HIV/AIDS Epidemic © 2000 John B. Pryor Illinois State University.
The Political Geography of AIDS
00002-E-1 – 1 December 2003 Global summary of the HIV/AIDS epidemic, December 2003 The ranges around the estimates in this table define the boundaries.
UNAIDS, Regional Support Team, Eastern and Southern Africa
How Economies Grow and Develop
The Tourism Geography of Latin America and the Caribbean.
GOOD JOBS WANTED : Labor Markets in América Latina GOOD JOBS WANTED : Labor Markets in América Latina Inter-American Development Bank Inter-American Development.
Latin America/Caribbean State of the Art HIV/AIDS Part Deux Paul R. De Lay, M.D. Chief, HIV/AIDS Division Global Bureau USAID March 13, 2001.
Comparing HIV and AIDS Prevalence within Countries By: Dan Evans Ida Nordestgaard Lacey McLean By: Dan Evans Ida Nordestgaard Lacey McLean 30 April 2009Economic.
Total health ODA commitments, US$ Billions.
HIV Therapy for the Developing World: A Global Health Challenge Harold W. Jaffe, MD Department of Public Health University of Oxford Oxford, UK.
The Millennium Science Initiative Promoting Science and Technology Capacity for Development Michael Crawford May 14, 2004.
HIV/AIDS: A Global and Regional Perspective AIDS in Post 2015 Development Agenda.
Lecture 2 Comparative Economic Development Copyright © 2009 Pearson Addison-Wesley. All rights reserved. 2-1.
Antiretroviral Treatment (ART) & Human resources Wim Van Damme Department of Public Health ITM, 17 October 2006.
Nassau, The Bahamas 18 November 2011 The Status Of The HIV Epidemic In The Caribbean: Implications for research, surveillance and priority setting at country.
ASADI Conference 2010 “Improving Access to Energy in Sub- Saharan Africa” November 2010 ASADI Conference 2010 “Improving Access to Energy in Sub-
THE ECONOMICS OF FOOD Disparity; Cycle of poverty; 1 st and 3 rd world gap.
DEA expression for technical efficiency (TE) 1 Max for j=1, …, n, u r, v i ≥ 0 for all i and r Subject to.
Technological Fix 1. Why is there inequality in access to technology ? a) What is technology and how is developed? b) Global distribution of a range of.
Population. Key knowledge and skills Distribution and composition Future patterns.
AIDS Epidemic Update December /06 e. AIDS Epidemic Update December /06 e TOTAL North America Eastern Europe & Central Asia Latin America.
Comparing HIV and AIDS Prevalence within Countries By: Dan Evans Ida Nordestgaard Lacey McLean By: Dan Evans Ida Nordestgaard Lacey McLean 30 April 2009Economic.
AFRICA HIV/AIDS AIDS DATA SOURCE: UNAIDS 2007 REPORT WORLD HEALTH ORGANIZATION.
YWCA Christchurch Inc.. UN MILLENIUM DEVELOPMENT GOALS Halfway point – 7th July 2007 Target date Goals Useful websites: UNA UK –
Key Affected Populations in Asia: Where are we and what is the way forward? Dr. Sai Subhasree Raghavan SAATHII, India Governing Council Member, IAS.
Copyright © 2009 Pearson Addison-Wesley. All rights reserved. Millennium Development Goals.
Estimation and Characterization of the Digital Divide Dr. Arturo Serrano S. CICESE RESEARCH CENTER Ensenada, Baja California, México.
Putting Health in All Policies into Practice Dr Kira Fortune 1 To provide the context of the HiAP Regional Plan of Action 2 To illustrate how the HiAP.
Europe and the Least Developed Countries (LDCs): trade, aid and the ACP states.
25 Years of AIDS – The Global Response 16 August 2006 XVI International AIDS Conference Toronto.
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
2016 SWA Meeting of Ministers of Water, Sanitation and Hygiene: Ministerial Meeting Addis Ababa, Ethiopia, 15 and 16 March Building blocks to achieve WASH.
Number of people living with HIV on antiretroviral therapy, global, 2010–2015
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
Global summary of the HIV and AIDS epidemic, December 2003
The HIV Response Where are we now?
Contents - HIV global slides
The State of the Epidemic in 2010
Overview of Global HIV Epidemic
Global summary of the HIV/AIDS epidemic, December 2003
27 years of responding to AIDS
Global summary of the AIDS epidemic, 2008
Global summary of the HIV/AIDS epidemic, December 2003
Global summary of the AIDS epidemic, 2008
27 years of responding to AIDS
Global epidemiology of injecting drug use
United Arab Emirates**
People who inject drugs
Drivers of Unit Cost Variation in Voluntary Medical Male Circumcision in Sub-Saharan Africa: A meta-regression analysis Drew Cameron UC Berkeley IAEN.
"3 by 5" progress December 2005.
27 years of responding to AIDS
Global summary of the HIV and AIDS epidemic, December 2004
FMA 601 Foreign Market Analysis
Contents - HIV global slides
Estimated number of people living with HIV and adult HIV prevalence
Accelerating the response for children affected by AIDS
Contents - HIV global slides
Global summary of the HIV/AIDS epidemic, December 2003
survey prevalence (%) (year)
Global summary of the HIV and AIDS epidemic, 2005
Global Summary of the HIV and AIDS Epidemic December 2004
Contents - HIV global slides
Global summary of the HIV and AIDS epidemic, 2005
Telecom Advisory Services, LLC
Presentation transcript:

Are Country Reputations for Good or Bad AIDS Leadership Deserved? An Exploratory Quantitative Analysis Nicoli Nattrass AIDS & Society Research Unit Centre for Social Science Research University of Cape Town

Testing the Conventional Wisdom Some countries (e.g. Brazil, Thailand, Uganda) are seen as demonstrating ‘good’ leadership on AIDS, whereas others (notably South Africa) are infamous for poor leadership. But are these reputations deserved, or do they just reflect different challenges, constraints and opportunities? This paper uses regression analysis of HAART coverage to explore which countries performed above expectation, as expected or below expectations.

Botswana Costa Rica Thailand Brazil Cuba Chile Mexico Cambodia Rwanda Namibia Venezuela South Africa Trinidad & Tobago Russia Latvia Kazakhstan Iran Uruguay

Highly Active Antiretroviral Therapy (HAART) coverage is positively associated with per capita income and HIV prevalence – but substantial variation remains.

level of development (GDP per capita) external support (being a PEPFAR country or in receipt of Global Fund 1 st round funding), scale of the epidemic (HIV prevalence, the absolute size of the HIV+ population and its distribution between urban and rural areas) other heath-related demands (non-AIDS DALY’s per capita) politico-institutional context (political stability and established democracy, % of births with skilled personnel). Sensitivity analysis also conducted controlling for language fractionalisation and region Explanatory variables – to account for factors governments cannot change in the short-term

Model 1 predicts: Being a PEPFAR focus country raises HAART coverage by 67%; For every 1% increase in HIV prevalence, HAART coverage rises by 0.2%; For every 1 percentage point increase in the share of the HIV- positive population in urban areas, HAART coverage rises by 2.5%; and Being an established democracy raises HAART coverage by 55%. Y = HAART coverage (Log) GDP per capita (PPP) (2005) PEPFAR focus country0.556**0.581***0.512** Global Fund 1st round recipient * (Log) adult HIV prevalence (2005)0.202**0.222***0.176* (Log) HIV+ population (2005) Proportion of HIV + people in urban areas0.881**0.793**0.522* Political stability (2005) Established democracy0.483**0.438**0.062 % of births with skilled health professionals (Log) non AIDS DALYs per capita (2002) Language fractionalisation *** Latin America & the Caribbean 0.982*** Southern Africa West Africa 0.561*** East Africa N8278 Adjusted R Selected Country Residuals Brazil Uganda South Africa

A regression residual of 0 means the country has precisely the predicted/expected level. Those countries with regression residuals ranging from -15 to +15 were classed as performing ‘as expected’. Those with residuals greater than 15 were classed as performing better than expected, and those with a negative residual below -15 were classed as performing below expectations. The figure displays the results from regression 1 for those countries whose regression residuals fell into the same category for all three specifications.

“I have been to every country in East and southern Africa, many of them two, three and four times. I can say confidently and categorically that every single country …. is working harder at treatment than is South Africa, with fewer relative resources, and in most cases nowhere near the infrastructure or human capacity of South Africa. It is a situation which is absolutely mystifying” Steven Lewis, 2005 (UN Special Envoy on AIDS) This supports the conventional wisdom about SA….

Further research is needed into those countries which performed significantly better than expected, but which do not have established reputations for good AIDS leadership (notably Mali, Burkina-Faso and Suriname). It is possible that in the general discourse about AIDS leadeship, insufficient attention has been paid to the role that governments can play in facilitating the importation and distribution of generic antiretrovirals (as occurs in Burkina-Faso) and in ensuring that the health system is well organised and efficient (as is the case in Suriname, but not in Trinidad and Tobago.